Home » Archive for June, 2011
Archive for June, 2011
Diabetes Vaccine Trial Fails Step Two
Jun. 29 | A study report published by The Lancet on June 27, 2011 said that an experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process. It is understood that the vaccine sought to protect insulin-producing...
Avastin Maker Appeals FDA Move
Jun. 29 | Swiss pharmaceutical giant Roche began a two-day appeal on June 28, 2011, asking the FDA to allow the top-selling drug Avastin to be used for breast cancer. In December 2010, the FDA said that Avastin was not an effective treatment for breast cancer,...
Cell Therapy Injection For Wrinkles Approved
Jun. 27 | The FDA recently approved a new type of therapy that uses a person’s own skin cells to create an injectable cosmetic plumper to smooth out laugh lines. Pennsylvania-based Fibrocell Science said that its application for license to market laViv, which...
Malaysian Drug Company Sealed Over Radiation
Jun. 27 | A pharmaceutical company was recently sealed by Malaysia’s nuclear energy regulator following a radiation leak earlier this month. The country’s Science, Technology and Innovation Minister Maximus Ongkili told reporters that the Atomic Energy...
US Supreme Court Allows Suit Against Baycol
Jun. 27 | The US Supreme Court recently gave the greenlight to a class-action suit by alleged victims of the anti-cholesterol drug Baycol, which was taken off the market in 2001 by German pharmaceuticals giant Bayer. The court said in a unanimous decision that...
‘Chantix Has Heart Risks’
Jun. 27 | New York City-based Pfizer has been asked by the FDA to change the label on its anti-smoking drug Chantix to warn of a slightly higher risk of heart problems in patients who already have cardiovascular disease. Also known as varenicline, Chantix was shown...
China Orders Augmentin Recall
Jun. 27 | Authorities in China recently ordered British pharmaceutical giant GlaxoSmithKline to recall its amoxicillin and clavulanate potassium suspension, sold under the tradename Augmentin. Augmentin is an antibiotic used to treat infections in children. The...
A New Compound To Treat TB
Jun. 23 | Researchers at the Tuberculosis Research Centre, Chennai, India, claimed to have invented a compound named “Transitmycin” to treat tuberculosis and HIV virus. Speaking to the media, Vanaja Kumar, Head, Department of Bacteriology said, “we...
Aris Global’s agOnDemand™ Swift Offers Rapid Deployment of Pharmacovigilance & Safety
Jun. 23 | Aris Global has strengthened its Software-as-a-Service (Saas) offerings, known as agOnDemand™, with the release of agOnDemand Swift as an ongoing commitment to provide all life science companies with an affordable, easy-to-use solution for adverse...
.
